Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Prostate Cancer

  Free Subscription


Articles published in J Cell Physiol

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    May 2020
  1. GUAN H, Peng R, Fang F, Mao L, et al
    Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer.
    J Cell Physiol. 2020 May 14. doi: 10.1002/jcp.29784.
    PubMed     Abstract available


  2. FAN Y, Ou L, Fan J, Li L, et al
    PLCepsilon regulates metabolism and metastasis signaling via HIF-1alpha/MEK/ERK pathway in prostate cancer.
    J Cell Physiol. 2020 May 7. doi: 10.1002/jcp.29698.
    PubMed     Abstract available


    April 2020
  3. QIU K, Zheng Z, Huang Y
    Long intergenic noncoding RNA 00844 promotes apoptosis and represses proliferation of prostate cancer cells through upregulating GSTP1 by recruiting EBF1.
    J Cell Physiol. 2020 Apr 24. doi: 10.1002/jcp.29690.
    PubMed     Abstract available


    February 2020
  4. CHEN Y, Wang K, Liu T, Chen J, et al
    Decreased glucose bioavailability and elevated aspartate metabolism in prostate cancer cells undergoing epithelial-mesenchymal transition.
    J Cell Physiol. 2020 Feb 4. doi: 10.1002/jcp.29490.
    PubMed     Abstract available


    October 2019
  5. AFSHARZADEH M, Hashemi M, Babaei M, Abnous K, et al
    PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells.
    J Cell Physiol. 2019 Oct 31. doi: 10.1002/jcp.29339.
    PubMed     Abstract available


  6. WANG ZY, Duan Y, Wang P
    SP1-mediated upregulation of lncRNA SNHG4 functions as a ceRNA for miR-377 to facilitate prostate cancer progression through regulation of ZIC5.
    J Cell Physiol. 2019 Oct 14. doi: 10.1002/jcp.29285.
    PubMed     Abstract available


  7. REZAEI S, Mahjoubin Tehran M, Sahebkar A, Jalili A, et al
    Androgen receptor-related micro RNAs in prostate cancer and their role in antiandrogen drug resistance.
    J Cell Physiol. 2019 Oct 10. doi: 10.1002/jcp.29275.
    PubMed     Abstract available


    September 2019
  8. PANDA PK, Patra S, Naik PP, Praharaj PP, et al
    Deacetylation of LAMP1 drives lipophagy-dependent generation of free fatty acids by Abrus agglutinin to promote senescence in prostate cancer.
    J Cell Physiol. 2019 Sep 23. doi: 10.1002/jcp.29182.
    PubMed     Abstract available


  9. CHEN J, Huang L, Zhu Q, Wang Z, et al
    MTSS1 hypermethylation is associated with prostate cancer progression.
    J Cell Physiol. 2019 Sep 20. doi: 10.1002/jcp.29172.
    PubMed     Abstract available


    August 2019
  10. SHA J, Han Q, Chi C, Zhu Y, et al
    Upregulated KDM4B promotes prostate cancer cell proliferation by activating autophagy.
    J Cell Physiol. 2019 Aug 29. doi: 10.1002/jcp.29117.
    PubMed     Abstract available


    July 2019
  11. WANG M, Yu W, Gao J, Ma W, et al
    MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1.
    J Cell Physiol. 2019 Jul 15. doi: 10.1002/jcp.29078.
    PubMed     Abstract available


  12. CHENG G, Song Z, Liu Y, Xiao H, et al
    Long noncoding RNA SNHG12 indicates the prognosis of prostate cancer and accelerates tumorigenesis via sponging miR-133b.
    J Cell Physiol. 2019 Jul 2. doi: 10.1002/jcp.29039.
    PubMed     Abstract available


    June 2019
  13. CAIRES-DOS-SANTOS L, da Silva SV, Smuczek B, de Siqueira AS, et al
    Laminin-derived peptide C16 regulates Tks expression and reactive oxygen species generation in human prostate cancer cells.
    J Cell Physiol. 2019 Jun 28. doi: 10.1002/jcp.28997.
    PubMed     Abstract available


    April 2019
  14. AZIZI R, Salemi Z, Fallahian F, Aghaei M, et al
    Inhibition of didscoidin domain receptor 1 reduces epithelial-mesenchymal transition and induce cell-cycle arrest and apoptosis in prostate cancer cell lines.
    J Cell Physiol. 2019 Apr 8. doi: 10.1002/jcp.28552.
    PubMed     Abstract available


    February 2019
  15. CAO R, Ke M, Wu Q, Tian Q, et al
    AZGP1 is androgen responsive and involved in AR-induced prostate cancer cell proliferation and metastasis.
    J Cell Physiol. 2019 Feb 28. doi: 10.1002/jcp.28366.
    PubMed     Abstract available


  16. FARHOOD B, Mortezaee K, Haghi-Aminjan H, Khanlarkhani N, et al
    A systematic review of radiation-induced testicular toxicities following radiotherapy for prostate cancer.
    J Cell Physiol. 2019 Feb 10. doi: 10.1002/jcp.28283.
    PubMed     Abstract available


    January 2019
  17. LI L, Du Z, Gao Y, Tang Y, et al
    PLCepsilon knockdown overcomes drug resistance to androgen receptor antagonist in castration-resistant prostate cancer by suppressing the wnt3a/beta-catenin pathway.
    J Cell Physiol. 2019 Jan 26. doi: 10.1002/jcp.28195.
    PubMed     Abstract available


  18. MUTHUSWAMI R, Bailey L, Rakesh R, Imbalzano AN, et al
    BRG1 is a prognostic indicator and a potential therapeutic target for prostate cancer.
    J Cell Physiol. 2019 Jan 22. doi: 10.1002/jcp.28161.
    PubMed     Abstract available


  19. LIU DC, Song LL, Liang Q, Hao L, et al
    Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression.
    J Cell Physiol. 2019 Jan 5. doi: 10.1002/jcp.27893.
    PubMed     Abstract available


    December 2018
  20. ZHANG G, He X, Ren C, Lin J, et al
    Long noncoding RNA PCA3 regulates prostate cancer through sponging miR-218-5p and modulating high mobility group box 1.
    J Cell Physiol. 2018 Dec 19. doi: 10.1002/jcp.27980.
    PubMed     Abstract available


  21. WANG F, Mao A, Tang J, Zhang Q, et al
    microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
    J Cell Physiol. 2018 Dec 10. doi: 10.1002/jcp.27989.
    PubMed     Abstract available


  22. ZHU WB, Zhao ZF, Zhou X
    AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1alpha/CXCR4 signaling pathway in prostate cancer.
    J Cell Physiol. 2018 Dec 7. doi: 10.1002/jcp.27831.
    PubMed     Abstract available


  23. AGHDAM SG, Ebrazeh M, Hemmatzadeh M, Seyfizadeh N, et al
    The role of microRNAs in prostate cancer migration, invasion, and metastasis.
    J Cell Physiol. 2018 Dec 7. doi: 10.1002/jcp.27948.
    PubMed     Abstract available


  24. VILLANI S, Gagliano N, Procacci P, Sartori P, et al
    Characterization of an in vitro model to study the possible role of polyomavirus BK in prostate cancer.
    J Cell Physiol. 2018 Dec 4. doi: 10.1002/jcp.27871.
    PubMed     Abstract available


    October 2018
  25. TADDEI ML, Cavallini L, Ramazzotti M, Comito G, et al
    Stromal-induced downregulation of miR-1247 promotes prostate cancer malignancy.
    J Cell Physiol. 2018 Oct 30. doi: 10.1002/jcp.27679.
    PubMed     Abstract available


  26. MADRIGAL-MARTINEZ A, Constancio V, Lucio-Cazana FJ, Fernandez-Martinez AB, et al
    PROSTAGLANDIN E2 stimulates cancer-related phenotypes in prostate cancer PC3 cells through cyclooxygenase-2.
    J Cell Physiol. 2018 Oct 26. doi: 10.1002/jcp.27515.
    PubMed     Abstract available


  27. SAGREDO AI, Sagredo EA, Pola V, Echeverria C, et al
    TRPM4 channel is involved in regulating epithelial to mesenchymal transition, migration, and invasion of prostate cancer cell lines.
    J Cell Physiol. 2018 Oct 21. doi: 10.1002/jcp.27371.
    PubMed     Abstract available


  28. ZHU L, Zhu Q, Wen H, Huang X, et al
    Mutations in GAS5 affect the transformation from benign prostate proliferation to aggressive prostate cancer by affecting the transcription efficiency of GAS5.
    J Cell Physiol. 2018 Oct 14. doi: 10.1002/jcp.27561.
    PubMed     Abstract available


    September 2018
  29. PASHIRZAD M, Shafiee M, Khazaei M, Fiuji H, et al
    Therapeutic potency of Wnt signaling antagonists in the pathogenesis of prostate cancer, current status and perspectives.
    J Cell Physiol. 2018 Sep 7. doi: 10.1002/jcp.27137.
    PubMed     Abstract available


    August 2018
  30. CAGGIA S, Chunduri H, Millena AC, Perkins JN, et al
    Novel role of Gialpha2 in cell migration: Downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells.
    J Cell Physiol. 2018 Aug 4. doi: 10.1002/jcp.26894.
    PubMed     Abstract available


    April 2018
  31. DUSCHARLA D, Reddy Kami Reddy K, Dasari C, Bhukya S, et al
    Interleukin-6 induced overexpression of valosin-containing protein (VCP)/p97 is associated with androgen-independent prostate cancer (AIPC) progression.
    J Cell Physiol. 2018 Apr 25. doi: 10.1002/jcp.26639.
    PubMed     Abstract available


  32. FARINA NH, Zingiryan A, Vrolijk MA, Perrapato SD, et al
    Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer intervention.
    J Cell Physiol. 2018 Apr 16. doi: 10.1002/jcp.26593.
    PubMed     Abstract available


  33. LIOTTI A, Cosimato V, Mirra P, Cali G, et al
    Oleic acid promotes prostate cancer malignant phenotype via the G protein-coupled receptor FFA1/GPR40.
    J Cell Physiol. 2018 Apr 16. doi: 10.1002/jcp.26572.
    PubMed     Abstract available


  34. MADRIGAL-MARTINEZ A, Fernandez-Martinez AB, Lucio Cazana FJ
    Intracrine prostaglandin E2 pro-tumoral actions in prostate epithelial cells originate from non-canonical pathways.
    J Cell Physiol. 2018;233:3590-3602.
    PubMed     Abstract available


    April 2017
  35. ZHU C, Zhu Q, Wu Z, Yin Y, et al
    Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer.
    J Cell Physiol. 2017 Apr 19. doi: 10.1002/jcp.25968.
    PubMed     Abstract available


    September 2016
  36. BORGES GT, Vencio EF, Quek SI, Chen A, et al
    Conversion of Prostate Adenocarcinoma to Small Cell Carcinoma-Like by Reprogramming.
    J Cell Physiol. 2016;231:2040-7.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: